tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

INmune Bio Inc

INMB
Add to Watchlist
1.750USD
-0.020-1.13%
Close 07-31 16:00（ET）Quotes delayed by 15 min
46.52MMarket Cap
LossP/E TTM

INmune Bio Inc

1.750
-0.020-1.13%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

INMB Financials

See INmune Bio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

INmune Bio Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.21
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
50.00K
257.14%
EPS(YoY)
-1.86
12.07%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
53.02%-0.20
52.25%-0.20
59.37%-0.24
-107.97%-1.05
29.22%-0.43
11.19%-0.41
-25.99%-0.60
-39.35%-0.50
-67.93%-0.61
-43.54%-0.47
---0.48
---0.36
---0.36
---0.33
----
----
----
----
----
----
Revenue
-100.00%0.00
--0.00
--0.00
--0.00
257.14%50.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-63.16%14.00K
-71.13%28.00K
-56.12%43.00K
187.50%46.00K
-76.69%38.00K
-40.49%97.00K
600.00%98.00K
--16.00K
3975.00%163.00K
1393.22%163.00K
--14.00K
--0.00
Net Profit
44.48%-5.41M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.50M
5.32%-6.54M
39.69%-5.83M
18.32%-7.72M
-2.75%-6.84M
-51.51%-6.90M
-201.81%-9.67M
-100.52%-9.46M
-215.73%-6.66M
Net Margin
----
----
----
----
75.27%-19478.00%
----
----
----
-357.85%-78750.00%
-399.36%-30028.57%
---19913.95%
---14132.61%
---17200.00%
---6013.40%
----
----
----
----
----
----
Gross Margin
----
----
----
----
0.00%100.00%
----
----
----
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
-100.00%0.00%
-76.06%4.73%
-55.35%9.49%
-20.24%15.92%
-3.13%17.40%
--19.74%
--21.26%
--19.96%
--17.97%
----
----
----
----
----
----
Income Statement
Revenue
-100.00%0.00
--0.00
--0.00
--0.00
257.14%50.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-63.16%14.00K
-71.13%28.00K
-56.12%43.00K
187.50%46.00K
-76.69%38.00K
-40.49%97.00K
600.00%98.00K
--16.00K
3975.00%163.00K
1393.22%163.00K
--14.00K
--0.00
Operating profit
41.32%-5.81M
42.18%-5.47M
39.50%-7.43M
18.33%-8.06M
10.09%-9.90M
-12.98%-9.47M
-44.07%-12.29M
-53.88%-9.87M
-71.52%-11.02M
-48.51%-8.38M
-14.58%-8.53M
-0.36%-6.41M
0.85%-6.42M
37.52%-5.64M
17.49%-7.44M
2.53%-6.39M
-42.44%-6.48M
-181.41%-9.03M
-87.19%-9.02M
-211.00%-6.55M
Net Profit
44.48%-5.41M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.50M
5.32%-6.54M
39.69%-5.83M
18.32%-7.72M
-2.75%-6.84M
-51.51%-6.90M
-201.81%-9.67M
-100.52%-9.46M
-215.73%-6.66M
Balance Sheet
Current assets
8.88%22.82M
31.88%29.89M
-14.45%30.67M
1.52%36.03M
-29.72%20.96M
-43.26%22.66M
-21.40%35.85M
-32.53%35.49M
-47.57%29.82M
-38.24%39.94M
-31.57%45.61M
-25.43%52.61M
-26.19%56.88M
-21.71%64.67M
-26.69%66.66M
60.15%70.55M
56.58%77.06M
244.40%82.61M
247.90%90.93M
592.71%44.05M
Total current liabilities
-32.03%5.39M
16.55%8.42M
-46.78%7.36M
-42.95%8.59M
-54.57%7.93M
-60.89%7.22M
-3.71%13.82M
15.29%15.05M
69.70%17.45M
69.12%18.46M
108.21%14.36M
471.33%13.05M
218.75%10.28M
150.47%10.92M
43.35%6.89M
-23.55%2.29M
46.90%3.23M
145.40%4.36M
226.30%4.81M
145.55%2.99M
Total assets
-31.70%25.82M
-18.23%32.35M
-36.80%33.36M
-28.16%37.68M
-19.29%37.80M
-30.59%39.56M
-15.82%52.78M
-24.77%52.45M
-36.69%46.83M
-30.31%57.00M
-25.18%62.70M
-20.60%69.72M
-21.59%73.98M
-18.16%81.80M
-22.17%83.80M
44.66%87.81M
43.23%94.35M
145.83%99.94M
151.47%107.67M
163.37%60.70M
Total liabilities
-23.79%6.19M
18.25%8.83M
-43.43%7.98M
-42.65%8.82M
-54.36%8.13M
-60.42%7.46M
-21.48%14.11M
-19.37%15.37M
-4.67%17.81M
-13.04%18.86M
-10.59%17.97M
6.66%19.07M
-0.15%18.68M
9.99%21.69M
3.49%20.09M
2.34%17.88M
709.30%18.71M
936.50%19.72M
1105.91%19.42M
1181.82%17.47M
Total equity
-33.87%19.62M
-26.71%23.52M
-34.38%25.38M
-22.15%28.87M
2.24%29.67M
-15.84%32.10M
-13.54%38.67M
-26.80%37.08M
-47.51%29.02M
-36.54%38.14M
-29.78%44.73M
-27.57%50.65M
-26.90%55.30M
-25.08%60.10M
-27.82%63.71M
61.76%69.93M
19.01%75.64M
107.01%80.22M
114.18%88.25M
99.37%43.23M
Cash Flow Statement
Net operating income
50.13%-3.40M
73.27%-2.94M
22.14%-5.44M
6.48%-7.38M
8.72%-6.82M
-223.82%-11.01M
-63.84%-6.99M
-148.46%-7.89M
-555.21%-7.48M
40.28%-3.40M
-26.64%-4.26M
33.31%-3.17M
87.13%-1.14M
41.77%-5.70M
57.50%-3.37M
16.64%-4.76M
-74.10%-8.87M
-308.74%-9.78M
-114.26%-7.92M
-213.99%-5.71M
Net investment
----
---143.00K
---193.00K
---706.00K
----
----
----
----
----
----
----
----
----
--0.00
--0.00
100.00%0.00
----
--0.00
--0.00
---15.00M
Net financing
-100.00%0.00
103.22%67.00K
-100.00%0.00
71.35%22.27M
310.96%5.27M
16.88%-2.08M
667.65%9.79M
--13.00M
---2.50M
---2.50M
---1.73M
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-97.44%729.00K
--0.00
127.80%52.94M
2148.79%14.95M

FAQs

What is the total revenue of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its total revenue reached 50.00K, with a year-on-year change of 14.00K.

What are the current assets of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its current assets were 29.89M, with a year-on-year change of 31.88.

What are the total assets of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its total assets of INmune Bio Inc were 32.35M, with a year-on-year change of -18.23.

What are the total liabilities of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its total liabilities of INmune Bio Inc were 8.83M, with a year-on-year change of 18.25.

What is the total equity of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its total equity of INmune Bio Inc was 23.52M, with a year-on-year change of -26.71.

What is the net operating income of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its net operating income of INmune Bio Inc was -30.87M, with a year-on-year change of 27.60.

What is the net financing of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its net financing of INmune Bio Inc was 27.61M, with a year-on-year change of 51.62.

What is the Earnings Per Share (EPS) of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.86, with a year-on-year change of 12.07.

What is the net income of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its net income was -45.93M, with a year-on-year change of -9.15.

What is the net margin of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its net profit margin was -91866.00, with a year-on-year change of 69.44.

What is the Return on Equity (ROE) of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its Return on Equity (ROE) was -165.16, with a year-on-year change of -37.83.

What is the Return on Assets (ROA) of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its Return on Assets (ROA) was -127.75, with a year-on-year change of -46.57.

What is the operating profit of INmune Bio Inc?

According to INmune Bio Inc's FY2025 earnings report, its operating profit was -30.87M, with a year-on-year change of 27.60.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy